Bilcare Ltd, a Rs 650 crore plus Pune based company engaged in providing solutions in pharma packaging and offering global clinical trial supplies services, has achieved strong performance during the year ended March 2008 and posted a net profit growth of 36 per cent. Its consolidated net profit went up to Rs 81.55 crore from Rs 59.92 crore in the previous year. The consolidated net sales increased by 59.5 per cent to Rs 650.68 crore from Rs 407.85 crore.
The board of directors has recommended equity dividend of 40 per cent for the financial year 2007-08.
Mohan Bhandari, chairman and managing director, said, "In last one year, we have significantly invested in creation of knowledge, innovation and technology. Going forward, these three verticals of strategic investments will enable Bilcare Ltd to emerge as leaders in counterfeit technology, clinical services and packaging solution.
The standalone net sales of Bilcare increased by 25.8 per cent to Rs 406.35 crore during the year ended March 2008 from Rs 322.98 crore in the previous year. Its standalone net profit increased by 5.3 per cent to Rs 61.69 crore from Rs 58.56 crore."